A possible primary cause of cancer: deficient cellular interactions in endocrine pancreas

Molecular Cancer

Volumn 11, Issue , 2012, Pages

  Israël, Maurice ^a  

^a NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ADRENALIN; GLUCAGON; HYDROCORTISONE; SOMATOMEDIN; SOMATOSTATIN;

ARTICLE; BIOSYNTHESIS; CATABOLISM; CELL GROWTH; CELL INTERACTION; CELL METABOLISM; CELL PROLIFERATION; GLUCOSE METABOLISM; GLYCOLYSIS; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MITOSIS; NEOPLASM; NEUROTRANSMISSION; PANCREAS ISLET; PANCREAS ISLET BETA CELL;

EID: 84865793246     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-11-63     Document Type: Article

References (23)

1. Israël M, Schwartz L. The metabolic advantage of tumor cells. Mol Cancer 2011, 10(70):1-12. 3024301, 21205300.
2. Bansal P, Wang Q. Insulin as a physiological modulator of glucagon secretion. Am J Physiol Endocrinol Metab 2008, 295:E751-E761. 10.1152/ajpendo.90295.2008, 18647881.
3. Sorenson RL, Garry DG, Breije TC. Structural and functional considerations of GABA in islets of Langerhans: β-cells and nerves. Diabetes 1991, 40(11):1365-1374. 10.2337/diabetes.40.11.1365, 1936599.
4. Braun M, Ramracheya R, Amisten S, Bengtsson M, Moritoh T, Zang Q, Johnson PR, Rorsman P. Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia 2009, 52:1566-1578. 10.1007/s00125-009-1382-z, 19440689.
5. Wendt A, Birnir B, Buschard K, Gromada J, Salehi A, Sewing S, Rorsman P, Braun M. Glucose inhibition of glucagon secretion from rat α-cells is mediated by GABA released from neighboring β-cells. Diabetes 2004, 53(4):1038-1045. 10.2337/diabetes.53.4.1038, 15047619.
6. Schweiger M, Schreiber R, Haemmerle G, Lass A, Fledelius C, Jacobsen P, Tornqvist H, Zechner R, Zimmermann R. Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 2006, 281(52):40236-41. 10.1074/jbc.M608048200, 17074755.
7. Newberne PM. Choline deficiency associated with diethanolamine carcinogenicity. (Toxicological highlights). Toxicol Sci 2002, 67:1-3. 10.1093/toxsci/67.1.1, 11961209.
8. Vafai SB, Stock JB. Protein phosphatase 2Amethylation: a link between elevated plasma homocysteine and Alzheimer's disease. FEBS Lett 2002, 518(1-3):1-4.
9. Egefjord L, Petersen AB, Rungby J. Zinc, alpha cells and glucagon secretion. Curr Diabetes Rev 2010, 6(1):52-7. 10.2174/157339910790442655, 20034370.
10. Baekkeskov S, Aanstoot H-J, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA- synthesizing enzyme glutamic acid decarboxylase. Nature 1990, 347:151-156. 10.1038/347151a0, 1697648.
11. Smismans A, Schuit F, Pipeleers D. Nutrient regulation of gamma- aminobutyric acid release from islet beta cells. Diabetologia 1997, 40:1411-1415. 10.1007/s001250050843, 9447948.
12. Kataoka Y, Fujimoto M, Alho H, Guidotti A, Geffard M, Kelly GD, Hanbauer I. Intrinsic gamma aminobutyric acid receptors modulate the release of catecholamine from canine adrenal gland in situ. JPET 1986, 239(2):584-590.
13. Gromada J, Ma X, Hoy M, Bokvist K, Salehi A, Bergen P-P, Rorsman P. ATP-sensitive K+ channel -dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1-/- mouse α-cells. Diabetes 2004, 53(S3):S181-S189.
14. Braun M, Ramracheya R, Amisten S, Bengtsson M, Moritoh Y, Zhang Q, Jojnson PR, Rorsman P. Somastotatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia 2009, 52:1566-1578. 10.1007/s00125-009-1382-z, 19440689.
15. Sorenson RL, Elde RP, Seybold V. Effect of Norepinephrin on insulin, glucagon, and somatostatin secretion in isolated perifused rat islets. Diabetes 1979, 28(10):899-904. 10.2337/diabetes.28.10.899, 383555.
16. Arvat E, Maccagno B, Ramunni J, Giordano R, DiVito L, Broglio F, Maccario M, Camanni F, Ghigo E. Glucagon is an ACTH secretagogue as effective as hCRH after intramuscular administration while it is ineffective when given intravenously in normal subjects. Pituitary 2000, 3(3):169-73. 10.1023/A:1011451710004, 11383481.
17. Mazurek S. Pyruvate kinase M2: A key enzyme of the tumor metabolome and its medical relevance. Biomedical Research (Aligarh) 2012, 23(2):SI 133-SI 141.
18. Palazzo AF, Mahadevan K. Alternative splicing rewires cellular metabolism to turn on the Warburg effect. Biomedical Research (Aligarh) 2012, 23(2):SI 25-SI 30.
19. Foster MC, Leapman RD, Li MX, Atwater I. Elemental composition of secretory granules in pancreatic islets of Langerhans. Biophys J 1993, 64:525-532. 10.1016/S0006-3495(93)81397-3, 1262355, 8457676.
20. Bucay AH. The biological significance of cancer: Mitochondria as a cause of cancer and the inhibition of glycolysis with citrate as a cancer treatment. Med Hypotheses 2007, 69:826-828. 10.1016/j.mehy.2007.02.002, 17368752.
21. Schwartz L, Abolhassani M, Guais A, Sanders E, Steyaert JM, Campion F, Israël M. Acombination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models:Preliminary results. Oncol Rep 2010, 23:1047-16.
22. Wheatley DN, Campbell E. Arginine deprivation, growth inhibition and tumor cell death: Deficient utilization of citrulline by malignant cells. Br J Cancer 2003, 89(3):573-576. 10.1038/sj.bjc.6601134, 2394371, 12888832.
23. Israël M, Lesbats B. A bioluminescent γ - aminobutyrate assay for monitoring its release from inhibitory nerve endings. J Neurochem 1996, 67:2624-7.